Barry Sloane
Known title: Chairman & CEOCIK: 0001124485
Barry Sloane's purchase track record
How the stock did after each of Barry Sloane's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
21
of 23 since May 18, 2022
Stock higher 6 months later
52%
3 months: 35%
Median 6-month return
+1.9%
3 months: -4.6%
Beat the S&P 500
33%
median -14.7% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/15/2026 | NEWT | $227K | -9.4% | pending | — |
| 5/21/2026 | IPM | $10K | -4.6% | pending | — |
| 1/14/2026 | NEWT | $50K | -8.7% | +10.4% | +9.3% |
| 11/3/2025 | NEWT | $102K | +32.0% | +28.1% | +5.1% |
| 6/20/2025 | NEWT | $21K | +20.4% | +21.8% | +14.5% |
| 5/29/2025 | NEWT | $109K | +12.1% | -0.7% | +15.8% |
| 5/13/2025 | NEWT | $228K | +5.2% | -9.1% | +16.3% |
| 12/23/2024 | NEWT | $39K | -2.2% | -15.1% | +0.9% |
| 11/26/2024 | NEWT | $44K | -13.8% | -20.1% | -1.7% |
| 9/23/2024 | NEWT | $472K | +11.1% | +8.7% | +0.9% |
| 8/14/2024 | NEWT | $81K | +20.8% | +5.8% | +10.9% |
| 6/17/2024 | NEWT | $127K | -11.6% | +8.6% | +11.0% |
| 5/15/2024 | NEWT | $142K | -11.1% | +7.4% | +12.8% |
| 12/13/2023 | NEWT | $40K | -22.1% | -7.2% | +15.2% |
| 11/27/2023 | NEWT | $68K | -17.7% | +1.9% | +16.6% |
| 9/22/2023 | NEWT | $30K | -1.2% | -28.2% | +21.2% |
| 9/7/2023 | NEWT | $67K | -18.2% | -31.5% | +15.9% |
| 8/15/2023 | NEWT | $35K | -20.0% | -35.7% | +11.6% |
| 6/16/2023 | NEWT | $16K | -0.7% | -8.3% | +7.0% |
| 5/17/2023 | NEWT | $56K | +55.5% | +22.2% | +8.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
IPM to Attend Lytham Partners Fall 2026 Investor Conference. Intelligent Protection Management Corp. will participate in the Lytham Partners Fall 2026 Investor Conference. The event offers a chance for the company to discuss its strategy and recent developments with investors and analysts. This participation may increase visibility for IPM among the conference audience. The company’s current technical signals show a neutral RSI and support at $1.80, but the conference focus remains on corporate updates.
Transaction History
| NEWT | ▲ Buy | Open Market | 5,000 | $71K | 6/15/2026 | View on chart |
| NEWT | ▲ Buy | Open Market | 5,000 | $71K | 6/15/2026 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $14K | 6/15/2026 | View on chart |
| NEWT | ▲ Buy | Open Market | 5,000 | $71K | 6/15/2026 | View on chart |
| IPM | ▲ Buy | Open Market | 5,000 | $10K | 5/21/2026 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,595 | $50K | 1/14/2026 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $20K | 11/3/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $20K | 11/3/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $21K | 11/3/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $20K | 11/3/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $20K | 11/3/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $10K | 6/20/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $10K | 6/20/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $33K | 5/29/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $11K | 5/29/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $33K | 5/29/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $33K | 5/29/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $22K | 5/19/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $34K | 5/19/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $22K | 5/19/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,500 | $17K | 5/19/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,500 | $17K | 5/19/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $23K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $23K | 5/13/2025 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $39K | 12/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $44K | 11/26/2024 | View on chart |
| NEWT | ▲ Buy | Grant | 11,532 | $0 | 10/4/2024 | View on chart |
| NEWT | ▼ Sell | Gift | 40,134 | $0 | 9/24/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 10,000 | $118K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 10,000 | $117K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 10,000 | $117K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,134 | $13K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 5,386 | $64K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,614 | $43K | 9/23/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,749 | $21K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 251 | $3K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 649 | $8K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $12K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $24K | 8/14/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 5,000 | $63K | 6/17/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $13K | 6/17/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 4,000 | $52K | 6/17/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 9,572 | $136K | 5/15/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 428 | $6K | 5/15/2024 | View on chart |
| NEWT | ▲ Buy | Open Market | 3,000 | $40K | 12/13/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 979 | $13K | 11/27/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 4,253 | $55K | 11/27/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $15K | 9/22/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $15K | 9/22/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $32K | 9/13/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $35K | 9/7/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 2,000 | $35K | 8/15/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 1,000 | $16K | 6/16/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 5,000 | $56K | 5/17/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 10,000 | $117K | 3/20/2023 | View on chart |
| NEWT | ▲ Buy | Open Market | 10,000 | $153K | 3/2/2023 | View on chart |
| NEWT | ▲ Buy | Grant | 61,652 | $0 | 12/29/2022 | View on chart |
| NEWT | ▲ Buy | Grant | 47,081 | $0 | 8/4/2022 | View on chart |
| NEWT | ▲ Buy | Open Market | 4,200 | $102K | 5/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NEWT: No Direct News in Last 7 Days
The recent news includes a comparison of Blackstone Secured Lending’s NAV and dividend projections with other BDC peers, and a discussion of how higher treasury yields are reshaping cash management strategies. Neither article directly references NEWT, so no immediate company‑specific developments are reported.
NEWT: No Direct News in Last 7 Days. The recent news includes a comparison of Blackstone Secured Lending’s NAV and dividend projections with other BDC peers, and a discussion of how higher treasury yields are reshaping cash management strategies. Neither article directly references NEWT, so no immediate company‑specific developments are reported.